Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.
Podcast Summary
Introduction
Dr. Warrick Bishop, a cardiovascular health expert, hosts the Healthy Heart Network podcast. In this episode, he explores recent research on glucosamine—a popular supplement commonly used for joint and cartilage health—and its potential cardiovascular benefits. The discussion centers on a recent UK meta-analysis of glucosamine trials that suggested a possible reduction in cardiovascular events among users.
Key Takeaways:
-
Recent pooled data from approximately 15 glucosamine trials suggests a potential reduction in cardiovascular events among glucosamine users
-
Glucosamine likely exerts anti-inflammatory effects, which may be beneficial since inflammation plays a role in plaque formation and coronary disease
-
The landmark Cantos trial demonstrated that targeted anti-inflammatory agents (canakinumab) significantly reduced cardiovascular events, providing strong evidence that inflammation is a key factor in heart disease
-
Current research is exploring other anti-inflammatory agents like colchicine (traditionally used for gout) as potential cardiovascular treatments
-
While the glucosamine data is promising and theoretically sound, it remains speculative and should not yet be considered standard therapy for heart disease prevention
-
Glucosamine appears to be safe for cardiovascular health with no adverse effects observed in current data
-
People taking glucosamine for joint pain can do so with confidence, knowing it may offer modest cardiovascular benefits as an added bonus
-
Further trials are ongoing to better understand the relationship between anti-inflammatory interventions and cardiovascular disease prevention



